- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01309503
Speech Intelligibility in Noise Using the Hearing in Noise Test (HINT)
Speech Intelligibility in Noise and Estimation of Binaural Benefits Using the Hearing in Noise Test (HINT). Studies on Normal Hearing Children and Adults, Groups of Hearing Aid Users and Cochlea Implant Users.
Studie Overzicht
Toestand
Conditie
Studietype
Inschrijving (Verwacht)
Contacten en locaties
Studie Locaties
-
-
-
Oslo, Noorwegen
- Werving
- Oslo University Hospital
-
Contact:
- Marte Myhrum, M.Sc
- Telefoonnummer: 004723071691
- E-mail: marte.myhrum@oslo-universitetssykehus.no
-
Hoofdonderzoeker:
- Marte Myhrum, M.Sc
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria for the different groups:
Normal hearing group (note that some subjects are already recruited in the normal hearing group):
- audiometric thresholds less than or equal to 25 dB HL for octave frequencies between 250 Hz and 8000 Hz
- Adults between age 18 and 50 years
- Children at different age groups between 6 and 12 years old
Unilateral hearing loss group
- Single-sided hearing loss.
- Using hearing aid or willing to try hearing aid on the side with hearing loss to estimate a potential binaural benefit with hearing aid.
- Unilateral hearing loss inclusion criteria is thresholds within 25 dBHL and 70 dBHL for frequencies {125,250,500} Hz. Inclusion region increasing linearly with octave frequency to 40 dBHL and 95 dBHL for frequency 8000Hz. In addition a single threshold outside this hearing threshold inclusion region is accepted.
- Contralateral normal hearing with audiometric thresholds less than or equal to 25 dB HL for octave frequencies between 250 Hz and 8000 Hz
Group with Severe hearing loss at high frequencies
- Inclusion criteria is bilateral hearing loss within hearing levels where frequencies below 750 Hz can be normal or elevated down to 65 dBHL, for frequencies 1000 Hz and 1500 Hz all HL thresholds are accepted, frequencies 2000 Hz and above have threshold criteria 85 dBHL or above.
Adult CI users with unilateral and bilateral CI
- All adult patients will be tested to the level of their performance.
- HINT SRTs will be collected if HINT score in quiet is above 70%.
Bilateral CI users (Children)
Sequential CIs group
- Children that has got two CIs in two different operations, and operations are not within one year.
- Inclusion of some of the patients participating in another ongoing sequential CI-study at the ENT department,and who has a HINT score above 70% in quiet. The requirement of a quiet percentage score above 70% is due to the bilateral benefit testing/estimation.
Simultaneous CIs group
- All children that has got two CIs in the same operation or sequentially within one year.
- Children older than 6 years old.
- Children as young as 5.5 years old can be included if they are considered ready for extended HINT testing.
Exclusion Criteria:
- None
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
---|
Normal hearing
Children and adults
|
Unilateral hearing loss
|
Severe hearing loss high frequencies
|
Adult CI users
Unilateral and bilateral CI
|
Bilateral CI users
Children and adults Sequential CIs Simultaneous CIs |
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Marte Myhrum, M.Sc., Oslo University Hospital
- Studie stoel: Greg Jablonski, PhD, Oslo University Hospital
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- 2010/743a (REK )
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .